XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Capital in Excess of Par [Member]
Treasury Stock [Member]
Retained Earnings (Accumulated Deficit) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Parent [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Capital in Excess of Par [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Retained Earnings (Accumulated Deficit) [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Parent [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Noncontrolling Interest [Member]
Balance at Dec. 31, 2022 $ 370,524 $ 287 $ 283,663 $ (45,538) $ 66,673 $ (3,349) $ 301,736 $ 68,788 $ 360,589 $ 287 $ 283,663 $ (45,538) $ 56,738 $ (3,349) $ 291,801 $ 68,788
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 (9,935)       (9,935)   (9,935)                  
Balance, shares at Dec. 31, 2022   28,663,827   (5,602,154)           28,663,827   (5,602,154)        
Net income 16,873       15,361   15,361 1,512                
Distributions to non-controlling interest (1,512)             (1,512)                
Stock-based compensation expense 1,036 $ 2 1,034       1,036                  
Issuance of restricted stock, net, shares   304,749                            
Withheld restricted stock for employees' tax obligations, shares   (91,169)                            
Withheld restricted stock for employees' tax obligations, value (768)   (768)       (768)                  
Forfeiture of restricted stock, net, shares   (9,843)                            
Exercise of stock options, value 292   292       292                  
Exercise of stock options, shares   44,583                            
Dividends paid on common stock (1,863)       (1,863)   (1,863)                  
Net change in unrealized gains on investments, net of tax 506         506 506                  
Ending balance at Mar. 31, 2023 375,153 $ 289 284,221 $ (45,538) 70,236 (2,843) 306,365 68,788                
Ending balance, shares at Mar. 31, 2023   28,912,147   (5,602,154)                        
Balance at Dec. 31, 2022 370,524 $ 287 283,663 $ (45,538) 66,673 (3,349) 301,736 68,788 360,589 $ 287 283,663 $ (45,538) 56,738 (3,349) 291,801 68,788
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 (9,935)       (9,935)   (9,935)                  
Balance, shares at Dec. 31, 2022   28,663,827   (5,602,154)           28,663,827   (5,602,154)        
Net income 32,555                              
Ending balance at Jun. 30, 2023 387,764 $ 289 285,435 $ (45,538) 82,539 (3,749) 318,976 68,788                
Ending balance, shares at Jun. 30, 2023   28,947,171   (5,602,154)                        
Balance at Dec. 31, 2022 370,524 $ 287 283,663 $ (45,538) 66,673 (3,349) 301,736 68,788 $ 360,589 $ 287 $ 283,663 $ (45,538) $ 56,738 $ (3,349) $ 291,801 $ 68,788
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ (9,935)       (9,935)   (9,935)                  
Balance, shares at Dec. 31, 2022   28,663,827   (5,602,154)           28,663,827   (5,602,154)        
Exercise of stock options, shares [1] 68,945                              
Net change in unrealized gains on investments, net of tax $ (300)                              
Ending balance at Dec. 31, 2023 $ 411,774 $ 291 288,046 $ (45,538) 103,883 (3,696) 342,986 68,788                
Ending balance, shares at Dec. 31, 2023 23,449,646 29,051,800   (5,602,154)                        
Balance at Mar. 31, 2023 $ 375,153 $ 289 284,221 $ (45,538) 70,236 (2,843) 306,365 68,788                
Balance, shares at Mar. 31, 2023   28,912,147   (5,602,154)                        
Net income 15,682       14,170   14,170 1,512                
Distributions to non-controlling interest (1,512)             (1,512)                
Stock-based compensation expense 1,214   1,214       1,214                  
Issuance of restricted stock, net, shares   11,734                            
Forfeiture of restricted stock, net, shares   (204)                            
Issuance in connection with vesting of restricted stock unit, Shares   23,211                            
Exercise of stock options, shares   283                            
Dividends paid on common stock (1,867)       (1,867)   (1,867)                  
Net change in unrealized gains on investments, net of tax (906)         (906) (906)                  
Ending balance at Jun. 30, 2023 387,764 $ 289 285,435 $ (45,538) 82,539 (3,749) 318,976 68,788                
Ending balance, shares at Jun. 30, 2023   28,947,171   (5,602,154)                        
Balance at Dec. 31, 2023 $ 411,774 $ 291 288,046 $ (45,538) 103,883 (3,696) 342,986 68,788                
Balance, shares at Dec. 31, 2023 23,449,646 29,051,800   (5,602,154)                        
Net income $ 11,536       10,024   10,024 1,512                
Distributions to non-controlling interest (1,512)             (1,512)                
Stock-based compensation expense 1,496 $ 1 1,495       1,496                  
Issuance of restricted stock, net, shares   296,178                            
Withheld restricted stock for employees' tax obligations, shares   (116,275)                            
Withheld restricted stock for employees' tax obligations, value (944)   (944)       (944)                  
Forfeiture of restricted stock, net, shares   (1,208)                            
Exercise of stock options, value $ 88   88       88                  
Exercise of stock options, shares 13,383 [1] 13,383                            
Purchase of common stock (in Shares)       (264,160)                        
Purchase of common stock $ (2,126)     $ (2,126)     (2,126)                  
Dividends paid on common stock (2,338)       (2,338)   (2,338)                  
Net change in unrealized gains on investments, net of tax (150)         (150) (150)                  
Ending balance at Mar. 31, 2024 417,824 $ 292 288,685 $ (47,664) 111,569 (3,846) 349,036 68,788                
Ending balance, shares at Mar. 31, 2024   29,243,878   (5,866,314)                        
Balance at Dec. 31, 2023 $ 411,774 $ 291 288,046 $ (45,538) 103,883 (3,696) 342,986 68,788                
Balance, shares at Dec. 31, 2023 23,449,646 29,051,800   (5,602,154)                        
Net income $ 20,149                              
Ending balance at Jun. 30, 2024 $ 422,789 $ 293 290,298 $ (49,179) 116,333 (3,744) 354,001 68,788                
Ending balance, shares at Jun. 30, 2024 23,211,990 29,262,204   (6,050,214)                        
Balance at Mar. 31, 2024 $ 417,824 $ 292 288,685 $ (47,664) 111,569 (3,846) 349,036 68,788                
Balance, shares at Mar. 31, 2024   29,243,878   (5,866,314)                        
Net income 8,613       7,101   7,101 1,512                
Distributions to non-controlling interest (1,512)             (1,512)                
Stock-based compensation expense 1,596 $ 1 1,595       1,596                  
Forfeiture of restricted stock, net, shares   (1,696)                            
Issuance in connection with vesting of restricted stock unit, Shares   17,155                            
Exercise of stock options, value $ 18   18       18                  
Exercise of stock options, shares 2,867 [1] 2,867                            
Purchase of common stock (in Shares)       (183,900)                        
Purchase of common stock $ (1,515)     $ (1,515)     (1,515)                  
Dividends paid on common stock (2,337)       (2,337)   (2,337)                  
Net change in unrealized gains on investments, net of tax 102         102 102                  
Ending balance at Jun. 30, 2024 $ 422,789 $ 293 $ 290,298 $ (49,179) $ 116,333 $ (3,744) $ 354,001 $ 68,788                
Ending balance, shares at Jun. 30, 2024 23,211,990 29,262,204   (6,050,214)                        
[1] The aggregate intrinsic value of exercised options, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was less than $0.1 million for the three and six months ended June 30, 2024 and was $0.1 million for the year ended December 31, 2023.